Bayer Aktiengesellschaft (WSE:BAY)
Poland · Delayed Price · Currency is PLN 155.94
+2.86 (1.87%)
At close: Mar 6, 2026
Bayer Aktiengesellschaft Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue | 45,575 | 46,606 | 47,637 | 50,739 | 44,081 |
Revenue Growth (YoY) | -2.21% | -2.16% | -6.11% | 15.10% | 6.48% |
Cost of Revenue | 18,527 | 20,831 | 19,687 | 18,886 | 17,045 |
Gross Profit | 27,048 | 25,775 | 27,950 | 31,853 | 27,036 |
Selling, General & Admin | 16,023 | 16,764 | 16,002 | 16,036 | 14,531 |
Research & Development | 5,650 | 5,974 | 5,370 | 6,168 | 5,326 |
Other Operating Expenses | 262 | -78 | -457 | 528 | -296 |
Operating Expenses | 21,935 | 22,660 | 20,915 | 22,732 | 19,561 |
Operating Income | 5,113 | 3,115 | 7,035 | 9,121 | 7,475 |
Interest Expense | -1,929 | -1,946 | -1,618 | -1,058 | -930 |
Interest & Investment Income | 471 | 521 | 484 | 379 | 346 |
Earnings From Equity Investments | -70 | -295 | -335 | -450 | 72 |
Currency Exchange Gain (Loss) | -169 | -203 | -449 | -219 | -385 |
Other Non Operating Income (Expenses) | 1,456 | 1,463 | 1,501 | -844 | -384 |
EBT Excluding Unusual Items | 4,872 | 2,655 | 6,618 | 6,929 | 6,194 |
Impairment of Goodwill | - | -3,263 | -6,690 | -734 | - |
Gain (Loss) on Sale of Investments | -20 | -3 | 20 | -150 | -26 |
Asset Writedown | 469 | 207 | 152 | 1,691 | 218 |
Legal Settlements | -7,850 | -548 | -1,193 | -791 | -3,689 |
Other Unusual Items | -600 | -1,382 | -528 | -2,275 | -651 |
Pretax Income | -3,129 | -2,334 | -1,621 | 4,670 | 2,046 |
Income Tax Expense | 466 | 212 | 1,321 | 504 | 1,024 |
Earnings From Continuing Operations | -3,595 | -2,546 | -2,942 | 4,166 | 1,022 |
Net Income to Company | -3,595 | -2,546 | -2,942 | 4,166 | 1,022 |
Minority Interest in Earnings | -25 | -6 | 1 | -16 | -22 |
Net Income | -3,620 | -2,552 | -2,941 | 4,150 | 1,000 |
Net Income to Common | -3,620 | -2,552 | -2,941 | 4,150 | 1,000 |
Net Income Growth | - | - | - | 315.00% | - |
Shares Outstanding (Basic) | 982 | 982 | 982 | 982 | 982 |
Shares Outstanding (Diluted) | 982 | 982 | 982 | 982 | 982 |
EPS (Basic) | -3.68 | -2.60 | -2.99 | 4.22 | 1.02 |
EPS (Diluted) | -3.68 | -2.60 | -2.99 | 4.22 | 1.02 |
EPS Growth | - | - | - | 314.58% | - |
Free Cash Flow | 3,443 | 4,590 | 2,366 | 4,144 | 2,478 |
Free Cash Flow Per Share | 3.50 | 4.67 | 2.41 | 4.22 | 2.52 |
Dividend Per Share | 0.110 | 0.110 | 0.110 | 2.400 | 2.000 |
Dividend Growth | - | - | -95.42% | 20.00% | - |
Gross Margin | 59.35% | 55.30% | 58.67% | 62.78% | 61.33% |
Operating Margin | 11.22% | 6.68% | 14.77% | 17.98% | 16.96% |
Profit Margin | -7.94% | -5.48% | -6.17% | 8.18% | 2.27% |
Free Cash Flow Margin | 7.56% | 9.85% | 4.97% | 8.17% | 5.62% |
EBITDA | 8,869 | 6,806 | 10,567 | 12,705 | 10,877 |
EBITDA Margin | 19.46% | 14.60% | 22.18% | 25.04% | 24.68% |
D&A For EBITDA | 3,756 | 3,691 | 3,532 | 3,584 | 3,402 |
EBIT | 5,113 | 3,115 | 7,035 | 9,121 | 7,475 |
EBIT Margin | 11.22% | 6.68% | 14.77% | 17.98% | 16.96% |
Effective Tax Rate | - | - | - | 10.79% | 50.05% |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.